Nonclinical Consultant _ Nonclinical Development _ Independent
Lhartvig
AeroLeads people directory · profile
Line Hartvig Email & Phone Number
Nonclinical consultant _ Nonclinical development _ Independent
at
Lhartvig
LinkedIn matched
✓ Verified Jun 2026
3 data sources
Profile completeness 86%
Current company
Role
Nonclinical consultant _ Nonclinical development _ Independent
Location
Hørsholm, Capital Region Of Denmark, Denmark
Who is Line Hartvig? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Line Hartvig is listed as Nonclinical consultant _ Nonclinical development _ Independent at Lhartvig, based in Hørsholm, Capital Region Of Denmark, Denmark. AeroLeads shows a matched LinkedIn profile for Line Hartvig.
Line Hartvig previously worked as Senior nonclinical advisor at Breye Therapeutics Aps and External senior nonclinical advisor at Klifo. Line Hartvig holds Ph.D. from Københavns Universitet - University Of Copenhagen.
Company email context
Email format at Lhartvig
This section adds company-level context without repeating Line Hartvig's masked contact details.
Lhartvig
Review company-level records connected to Line Hartvig before choosing the right outreach path.
Profile bio
About Line Hartvig
• More than 20 years of experience from the pharma/biotech industry and more than 15 years of project management • I have a large network of consultants, CROs, and venture capitalists • My focus area is primarily on the preclinical (research; pharmacology, selection of lead, in vitro/in vivo PK/ADME) and nonclinical (NC) drug development, covering pharmacology and PK/ADME/DDI. • Defining the overall IND-enabling NC data package. • Arranging and monitorering of pharmacology and PK/ADME/DDI studies. • Experience with small-molecule based compounds (NCE, peptides, peptide-conjugates) and biopharmaceuticals (biologics, antibodies, and antibody-drug conjugates) • Writing of IB/IND/CTA/eCTD/preIND For the last 12 years, working as independent consultant for small and medium-size biotech companies, I participated in moving 11 drugs from the early preclinical discovery stage into phase 1-3 clinical trials. Prior to working as a freelancer, I worked for biotech companies in permanent positions. Evaluation of proposals, projects and comapnies is also within my expertise area. I previously worked for a venture capitalist, investing in biotech companies, and currently I work as a jury member and evaluator for EIC and at the Innovationsfonden in Denmark.
Current workplace
Line Hartvig's current company
Company context helps verify the profile and gives searchers a useful next step.
21 roles
Line Hartvig work experience
A career timeline built from the work history available for this profile.
Senior Nonclinical Advisor
Current
Dec 2022 - Present
External Senior Nonclinical Advisor
Current
Jun 2020 - Present
Nonclinical Consultant _ Nonclinical Development _ Independent
Current
Lhartvig
Drug discovery and nonclinical development
Apr 2012 - Present
Member Of Expert Panel At Innoexplorer
Jun 2019 - Dec 2024
Jury Member At Eic Transition
Jul 2022 - Dec 2023
Head Of Nonclinical Development
Nov 2020 - May 2023
Expert/Evaluator At Horizon 2020 Sme Instrument
Jan 2018 - Apr 2021
Expert/Evaluator At Imi 2
Sep 2015 - Apr 2021
Expert/Evaluator At Horizon 2020
Mar 2014 - Apr 2021
Ceo
Retipharma
Lead compound showed insufficient pharmacological effect. Company was closed.------------------------------------------------------------------------------------------------------------------Old text: RetiPharma strives to offer the first vision-saving therapeutic treatment to aid people suffering from retinal disorders, which involves detachment of the.
Jun 2019 - Sep 2020
Toxicologist
Non-clinical planning, exploratory safety assessment, toxicology study design and monitoring.
Jun 2015 - Aug 2016
Nonclinical Development Consultant
Primary assignments in Non-clinical safety Department: Study design and monitoring. IND writing for an antibody drug conjugate (ADC); HuMax-TF-ADC. Secondary work: Construction of business case processes and documents/templates.
May 2012 - Mar 2014
Early Stage Business Development Manager
Proactive scouting within dermatology, evaluating opportunities in treatment of psoriasis (oral treatment) and orphan skin diseases. Analysis of market potentials, competitor analysis and valuations of projects/companies.. Performance of due diligence. Identifying Virobay, Inc. as a valuable business partner (early stage opportunity within oral treatment.
Aug 2010 - Sep 2011
Scientific Analyst
Analysis and evaluation of Investment opportunities: biotech companies, technolgies,projects and plans. Pipeline management, identification of investment opportunities and deal-flow sourcing. Due diligence. Communication with key opinion leaders/Experts. Market and competitor analysis.
Mar 2008 - Jun 2010
Principal Scientist
Biologic drug characterisation, pharmacological assessment, mode of action studies, bioanalysis/pharmacokinetic analysis, validation, study monitoring. Co-writer of two IND/IMPD/IBs.
Jan 2005 - Feb 2008
Senior Scientist
Molecular pharmacological assessment, establishment of cell-based assays, selection of best peptide drug candidates (gap junction modulators, GPCR modulators). Innovation: proposal of new projects/new targets.
Sep 2001 - Dec 2004
Senior Scientist
Xenopus Oocyte-based electrophysiology. Ion channel targets: voltage-gated ion channel and modulators. Development of ion channel-expressing cell lines. Proposal of new Projects/drug targets in the cardiovascular disease area.
Dec 2000 - Aug 2001
Scientist
Temporary position: 1 year.Xenopus Oocyte-based electrophysiology for pharmacological evaluations of lead candidate drugs, acting on ligand-gated ion channels.
Jun 2000 - Nov 2000
Post-Doc And Interim Head Of Institute
Interim Head of Institute (1 year): Management of staff (16 people). Proposal of new projects and establishment of genetic research. Fundraising.Post-doc: Establishment of patch-clamp in CHO cells: pharmacological assessment of GABAA,GABAC or nicotinic acetylcholine receptor. Binding site exploration in GABAA receptor. Site-directed mutagenesis studies.
Sep 1997 - May 2000
Sep 1994 - Aug 1997
4 education records
Line Hartvig education
Ph.D.
Københavns Universitet - University Of Copenhagen
M.Sc., Biochemistry
Københavns Universitet - University Of Copenhagen
Education record
Himmelev Gymnasium
Ph.D. Student
Aarhus University
FAQ
Frequently asked questions about Line Hartvig
Quick answers generated from the profile data available on this page.
What company does Line Hartvig work for?
Line Hartvig works for Lhartvig.
What is Line Hartvig's role at Lhartvig?
Line Hartvig is listed as Nonclinical consultant _ Nonclinical development _ Independent at Lhartvig.
Where is Line Hartvig based?
Line Hartvig is based in Hørsholm, Capital Region Of Denmark, Denmark while working with Lhartvig.
What companies has Line Hartvig worked for?
Line Hartvig has worked for Lhartvig, Breye Therapeutics Aps, Klifo, Innovation Fund Denmark, and European Innovation Council And Smes Executive Agency (Eismea).
How can I contact Line Hartvig?
You can use AeroLeads to view verified contact signals for Line Hartvig at Lhartvig, including work email, phone, and LinkedIn data when available.
What schools did Line Hartvig attend?
Line Hartvig holds Ph.D. from Københavns Universitet - University Of Copenhagen.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial